Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous revision tag and signaling a minor update to the page’s revision history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a new version of the page. This typically reflects minor edits or maintenance without altering the study details visible to users.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page shows a newer revision number, indicating a software/build update; there are no evident changes to the study details or other content in the data provided.SummaryDifference0.1%

- Check51 days agoChange DetectedEnrollment status now indicates that the study is no longer enrolling; additional help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header formatting was adjusted while the page revision advanced to v3.6.0.SummaryDifference0.4%

- Check58 days agoChange DetectedThe page revision tag was updated to v3.5.5, replacing the previous v3.5.4, indicating a minor page revision.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows a new revision label, v3.5.4, replacing the previous v3.5.3. This reflects a software/asset update and does not modify the study details or content presented on the page.SummaryDifference0.1%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.